SCHEMBL25435406

SCHEMBL25435406

Cc1nocc1CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12869089 0.77 GABRA1 (0.34)
SCHEMBL19987785 0.77 SIRT2 (0.36)
SCHEMBL1208452 0.76
SCHEMBL2095716 0.76
SCHEMBL1207509 0.76
SCHEMBL9844943 0.76 SIRT2 (0.35)
SCHEMBL12424232 0.74
SCHEMBL24908116 0.73
SCHEMBL25088263 0.73
SCHEMBL12384343 0.73 CNR2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023169226-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF Impact Therapeutics (Shanghai), Inc (CN) 2023-09-14 WO disclosed
CN-107406422-A Pyrazole derivatives as sGC stimulants 铁木医药有限公司 2017-11-28 CN disclosed